Skip to main content
    M

    Medpace Holdings Inc (MEDP)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $616.63
    +6.74 (+1.11%)

    Market Cap: $17.02B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    92%(36/39)
    Avg Surprise
    +13.04%
    Streak
    12 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$4.46
    Range$4.31 - $4.69
    8 analysts
    EPS Revisions
    6
    0
    7d
    6
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$4.32+3.2%
    60d ago$4.44+0.5%
    30d ago$4.44+0.5%
    7d ago$4.44+0.5%
    Current$4.46
    Revenue Consensus
    $714M
    Range$706M - $736M
    11 analysts
    Period ending Dec 31, 2026
    EPS Consensus$5.29
    Range$5.07 - $5.95
    10 analysts
    Revenue Consensus
    $751M
    Range$728M - $787M
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$5.29---
    Sep 26EST
    		-$4.46---
    Jun 26
    Reported Jul 22
    		$4.25$4.08+4.17%Beat+37.1%
    Mar 26
    Reported Apr 22
    		$4.28$3.96+8.08%Beat+16.6%
    Dec 25
    Reported Feb 9
    		$4.67$4.18+11.72%Beat+26.9%
    Sep 25
    Reported Oct 22
    		$3.86$3.57+8.12%Beat+28.2%
    Jun 25
    Reported Jul 21
    		$3.10$3.00+3.33%Beat+12.3%
    Mar 25
    Reported Apr 21
    		$3.67$3.07+19.54%Beat+14.0%
    Dec 24
    Reported Feb 10
    		$3.68$3.12+18.12%Beat+49.6%
    Sep 24
    Reported Oct 21
    		$3.01$2.87+4.88%Beat+34.4%
    Jun 24
    Reported Jul 22
    		$2.76$2.63+4.94%Beat+41.5%
    Mar 24
    Reported Apr 22
    		$3.22$2.49+29.32%Beat+41.2%
    Dec 23
    Reported Feb 12
    		$2.46$2.22+10.81%Beat+16.0%
    Sep 23
    Reported Oct 23
    		$2.24$2.19+2.28%Beat+8.2%
    Jun 23
    Reported Jul 24
    		$1.95$2.00-2.50%Miss+31.8%
    Mar 23
    Reported Apr 24
    		$2.28$1.88+21.28%Beat+33.3%
    Dec 22
    Reported Feb 13
    		$2.12$1.79+18.44%Beat+60.6%
    Sep 22
    Reported Oct 24
    		$2.07$1.54+34.42%Beat+56.8%
    Jun 22
    Reported Jul 25
    		$1.48$1.39+6.47%Beat+35.8%
    Mar 22
    Reported Apr 25
    		$1.71$1.31+30.53%Beat+44.9%
    Dec 21
    Reported Feb 14
    		$1.32$1.25+5.60%Beat-2.2%
    Sep 21
    Reported Oct 25
    		$1.32$1.12+17.86%Beat+15.8%
    Jun 21
    Reported Jul 26
    		$1.09$1.03+5.83%Beat+60.3%
    Mar 21
    Reported Apr 26
    		$1.18$1.07+10.28%Beat+47.5%
    Dec 20
    Reported Feb 15
    		$1.35$1.24+8.87%Beat+58.8%
    Sep 20
    Reported Oct 26
    		$1.14$1.16-1.72%Miss+60.6%
    Jun 20
    Reported Jul 27
    		$0.68$0.44+54.55%Beat-16.0%
    Mar 20
    Reported Apr 28
    		$0.80$0.75+6.67%Beat+25.0%
    Dec 19
    Reported Feb 24
    		$0.85$0.75+13.33%Beat+11.8%
    Sep 19
    Reported Oct 28
    		$0.71$0.71+0.00%Beat+6.0%
    Jun 19
    Reported Jul 29
    		$0.81$0.64+26.56%Beat+32.8%
    Mar 19
    Reported Apr 29
    		$0.64$0.61+4.92%Beat+16.4%
    Dec 18
    Reported Feb 25
    		$0.76$0.67+13.43%Beat+94.9%
    Sep 18
    Reported Oct 29
    		$0.67$0.63+6.35%Beat+67.5%
    Jun 18
    Reported Jul 30
    		$0.61$0.43+41.86%Beat+60.5%
    Mar 18
    Reported Apr 30
    		$0.55$0.44+25.00%Beat+61.8%
    Dec 17
    Reported Feb 26
    		$0.39$0.38+2.63%Beat+11.4%
    Sep 17
    Reported Oct 30
    		$0.40$0.36+11.11%Beat-
    Jun 17
    Reported Jul 31
    		$0.38$0.30+26.67%Beat-
    Mar 17
    Reported May 1
    		$0.34$0.37-8.11%Miss-
    Dec 16
    Reported Feb 27
    		$0.35$0.34+2.94%Beat-

    Key Metrics

    Valuation
    P/E Ratio36.14EV/EBITDA27.59x
    Price/FCF24.58xFCF Yield4.07%
    Profitability
    Profit Margin17.70%Operating Margin20.80%
    ROE162.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio0.73xQuick Ratio0.73x
    Trading Statistics
    Beta1.18Avg Volume258.84K
    52-Week High$677.9052-Week Low$373.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$608.65
    SMA 20$614.36
    SMA 50$604.91
    SMA 200$525.63
    EMA 10$612.06
    EMA 20$610.68
    EMA 50$596.98
    EMA 200$535.86

    MACD

    Line: 2.86Signal: 3.60Hist: -0.74

    ADX

    ADX: 23.7+DI: 26.4-DI: 13.2

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down4.0
    PSAR$593.52

    Bollinger Bands

    Upper Band$632.34
    Lower Band$596.39
    %B Position585%(Upper)
    Band Width0.56

    RSI (14-Day)

    Neutral
    53.8

    Momentum Oscillators

    Stoch %K50.9
    Stoch %D47.6
    Williams %R-47.1
    ROC (10d)-1.2%
    Momentum-7.55
    CCI (20d)38.0
    MFI (14d)52.9

    Volatility Measures

    ATR (14d)$18.40(3.0%)
    StdDev (20d)8.99
    Hist Vol27.5%(Moderate)

    Volume Flow

    VWAP$617.76
    OBV6.8M
    AD Line11.0M
    CMF (20d)0.084

    Volume Metrics

    Avg Vol (20d)259.1K
    Vol Ratio1.2x
    VWMA (20d)$614.76

    Pivot Points

    R3$628.54
    R2$624.65
    R1$617.27
    Pivot Point$613.38
    S1$606.00
    S2$602.10
    S3$594.72

    Advanced Oscillators

    TSI5.19
    Ultimate Osc42.1
    KST11.67

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$707.33M$706.60M$708.45M$659.90M$603.31M$558.57M$536.59M$533.32M$528.10M$511.04M$498.40M$492.50M
    Cost of Revenue$0$0$503.13M$0$0$0$358.27M$0$0$0$361.60M$0
    Gross Profit$707.33M$706.60M$708.45M$659.90M$603.31M$558.57M$536.59M$533.32M$528.10M$511.04M$498.40M$492.50M
    Operating Expenses$560.51M$565.10M$555.18M$518.10M$476.98M$445.05M$411.21M$421.04M$422.95M$406.98M$411.08M$407.59M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$48.10M$47.92M$44.92M$48.08M$46.66M$57.90M$45.43M$49.22M$41.45M$44.08M$42.51M$41.41M
    Operating Income$146.82M$141.50M$153.27M$141.81M$126.33M$113.52M$125.38M$112.27M$105.15M$104.07M$87.32M$84.91M
    Interest Income$4.99M$5.12M$3.72M$1.52M$1.08M$6.46M$7.88M$7.53M$5.46M$4.12M$1.84M$-105,000
    Interest Expense$0$0$0$0$1.80M$0$0$0$0$0$0$1.71M
    Income Before Tax$151.66M$147.59M$156.83M$142.84M$124.54M$118.17M$133.88M$118.78M$110.48M$112.78M$90.71M$83.20M
    Income Tax Expense$30.30M$23.72M$21.70M$31.70M$34.28M$3.58M$16.86M$22.35M$22.13M$10.19M$12.41M$12.65M
    Net Income$121.36M$123.87M$135.13M$111.14M$90.26M$114.59M$117.02M$96.43M$88.35M$102.59M$78.30M$70.55M
    EBITDA$153.39M$149.38M$160.24M$148.37M$130.47M$118.64M$133.50M$118.77M$112.25M$115.65M$95.83M$90.18M
    EBIT$146.68M$142.47M$153.11M$141.32M$123.46M$111.71M$126.00M$111.25M$105.02M$108.66M$88.86M$83.31M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MEDP

    News

    Form 4 Medpace Holdings Inc: Susan E. Burwig (Exec. VP, Operations) For: 12 October

    This article reports on a Form 4 filing for Medpace Holdings Inc, indicating that Susan E. Burwig, the Executive Vice President of Operations...

    Investing.com India•10/15/26•Neutral

    Mizuho lifts target to USD 700 for Medpace stock

    Mizuho Securities has increased its price target for Medpace (MEDP) stock from USD 665.00 to USD 700.00, representing an 11.03% increase from its current Nasdaq price. The company is set to report its third-quarter 2026...

    ad-hoc-news.de•10/15/26•Bullish

    Medpace Holdings, Inc. (MEDP) Options Chain

    This article provides detailed options chain data for Medpace Holdings, Inc. (MEDP), including call and put options. It lists various strike prices, last trade dates, last prices, bid/ask spreads, change, percent change...

    Yahoo! Finance Canada•10/15/26•Neutral

    Form 4 Medpace Holdings Inc: Susan E. Burwig (Exec. VP, Operations) For: 12 October

    This article reports on a Form 4 filing for Medpace Holdings Inc, detailing a transaction by Susan E. Burwig, Executive VP of Operations. The filing pertains to activity on October 12th.

    Investing.com Canada•10/14/26•Neutral

    At $166.73 a share, Medpace (MEDP) EVP Susan E. Burwig exercised options for 3,000 shares.

    Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc. (MEDP), exercised options for 3,000 common shares on October 12, 2026...

    Stock Titan•10/14/26•Neutral

    MEDP Valuation and Fair Value

    P/E
    36.1x
    Forward P/E
    31.9x
    EV/EBITDA
    27.6x
    P/FCF
    24.6x
    PEG
    2.9x
    P/B
    40.0x
    See GNG's fair value

    MEDP Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    20.8%
    Net margin
    17.7%
    ROE
    162.1%
    FCF margin
    25.4%
    FCF yield
    4.1%

    MEDP Competitors

    CompanyTicker
    Hologic IncHOLX
    Revvity Inc.RVTY
    Zimmer Biomet Holdings IncZBH
    Exelixis IncEXEL
    EXACT Sciences CorporationEXAS
    Solventum Corp.SOLV
    Viatris IncVTRS
    Ascendis Pharma ASASND

    Sector: Healthcare

    MEDP Analyst Ratings

    Consensus
    Hold
    Analysts
    14
    Strong Buy
    1
    Buy
    1
    Hold
    11
    Sell
    1
    Strong Sell
    0

    MEDP Bull Case vs Bear Case

    Bull case

    • MEDP converts 25.4% of revenue into free cash flow.
    • MEDP beat EPS estimates in 100.0% of its last 8 reported quarters.
    • MEDP grew quarterly revenue 17.2% year over year.

    MEDP Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    9.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $4.46
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    6 up, 1 down

    Frequently Asked Questions About MEDP

    Does MEDP pay dividends?

    Medpace Holdings Inc (MEDP) does not currently pay a regular dividend.

    What is MEDP's P/E ratio?

    Medpace Holdings Inc has a price-to-earnings (P/E) ratio of 36.14.

    What is MEDP's market cap?

    Medpace Holdings Inc (MEDP) has a market capitalization of $17.02B with a current stock price of $616.63.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In